Germany’s Sirion Biotech has signed a license and collaboration agreement with major French pharma Sanofi on viral vector-based gene therapy. Financial terms of the...
For mRNA vaccine maker Moderna, March is gearing up to roar in like a lion, with the tailwind setting the pace for the year ahead. Reporting 2020 financial results on Feb...
New US president Joe Biden has pledged to release altogether $4 billion in US funding to support Gavi, the global vaccine alliance. The president was expected to announce...
US biopharma AbbVie and compatriot biotech Caribou Biosciences have entered into a multi-year collaboration and license agreement to research and develop chimeric antigen...
PolyPeptide Group has appointed Raymond De Vré as its new Chief Executive Officer (CEO). He will succeed Jane Salik who, after 15 years in this position, will concentrate...
German biotech CureVac has begun a rolling submission with the European Medicines Agency (EMA) for its mRNA-based Covid-19 vaccine candidate currently in Phase 2b/3...
BioNTech this week kicked off production at the Marburg, Germany, plant it acquired last year from Novartis. The plant will focus on making mRNA batches, the beginning of...
The EU appears to be close to signing a Covid-19 vaccine supply deal with US biotech manufacturer Novavax. The Reuters news agency cites two EU officials involved in...
Lonza has signed a definitive agreement to divest its Specialty Ingredients business to Bain Capital and Cinven for an enterprise value of CHF 4.2 billion.
German chemical producer Wacker Chemie is acquiring 100% of San Diego, California- headquartered CDMO Genopis from its two South Korean owners, Helixmith and Medivate...
